C4 Therapeutics' GAAP loss for 3 months of 2022 was $31.62 million, up 50.8% from $20.971 million in the prior year. Revenue increased 3.1% to $7.654 million from $7.426 million a year earlier.
C4 Therapeutics' GAAP loss for 3 months of 2022 was $31.62 million, up 50.8% from $20.971 million in the prior year. Revenue increased 3.1% to $7.654 million from $7.426 million a year earlier. 
ir.c4therapeutics.com
English (US) 